Healthcare
The companies featured on PressReleaseFinder are active in several industries.
31 Oct 2007
DSM Biomedical Chairs Session on Antimicrobial Surfaces at BioInterface 2007
SAN MATEO, Calif. – Oct. 31, 2007 – At the BioInterface 2007 Workshop and Symposium, Aylvin Dias, Ph.D, R&D program manager for DSM Biomedical, will chair a double session on antimicrobial surfaces with emphasis on biofilms, biofouling and biocidal approaches. This session will be attended by a number of industrial and academic opinion leaders to discuss the latest developments on and challenges to medical device associated infections. During the session, Dr. Dias will introduce ComfortCoat™, DSM’s new coating that addresses catheter associated urinary tract infections (CAUTI).
22 Oct 2007
中国兴奋剂检测中心与赛默飞世尔科技携手合作
中国，北京（2007年10月19日）服务科学，世界领先的赛默飞世尔科技（原热电公司）与中国兴奋剂检测中心在北京签署2008年奥运会兴奋剂检测项目合作计划书。协议确定了赛默飞世尔参与和支持2008年奥运会兴奋剂检测的仪器和技术服务，以保证奥运会期间兴奋剂的检测任务的完成。反兴奋剂是目前各国政府和体育界共同面临的问题，而赛默飞世尔科技与国际兴奋剂检测机构的合作可以追溯到世界反兴奋剂斗争的最开始。
Shanghai, China, September 26, 2007 ---- Rohm and Haas’s ion exchange resin facility in China is one of four Rohm and Haas ISO-certified sites expanding operations for a wide range of ion exchange resins manufacture. The expansion complements various developments already underway at the company’s network of ion exchange resin sites in the USA, Europe and Asia. 
DSM today announced the start of an initiative to enter the market of ultra high molecular weight polyethylene (UHMWPE) for use in Total Joint Arthroplasty and other medical devices. In the upcoming years DSM Biomedical will make significant investments in a research and development program focused on UHMWPE-grades with optimized material properties, specifically aimed at currently unmet clinical needs in this orthopedic segment. This strategic material development links on to DSM’s activities in the Emerging Business Area of Biomedical Materials, which is an important element of DSM’s strategy Vision 2010 – Building on Strengths. 
URMOND (NL), 13 September, 2007 – DSM Dyneema today announced that Dyneema Purity®, its high-performance specialty polyethylene fiber developed specifically for medical applications, has been shown to promote better tissue formation than traditional polyester in orthopedic suture applications. In independent testing by NAMSA’s Biomatech Lab, braids made of Dyneema Purity® exhibited enhanced fibro-connective tissue formation as well as reduced irritation and lower inflammation compared to polyester. Coupled with the exceptional mechanical performance of Dyneema Purity®, the world’s strongest fiber, these results make this ultra high molecular weight polyethylene (UHMWPE) an excellent alternative to polyester. 
BERGEN OP ZOOM, THE NETHERLANDS — August 09, 2007 — GE Plastics has introduced in-house co-injection processing expertise for the healthcare industry. This processing technology enables application designers and developers of healthcare packaging to overcome limitations of mono-material solutions. 